STOCK TITAN

Cullinan Oncology, Inc. to Participate in the 20th Annual Needham Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Cullinan Oncology (Nasdaq: CGEM) has announced that CFO Jeff Trigilio will present at the 20th Annual Needham Virtual Healthcare Conference on April 13, 2021, at 11:45 am EDT. The presentation will be accessible only to registered attendees through the Needham conference portal. Interested investors can schedule meetings with Trigilio by contacting their Needham representative. Cullinan Oncology is focused on developing a diversified pipeline of targeted and immuno-oncology therapeutic candidates to drive shareholder returns.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., April 07, 2021 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) announced today that the company’s Chief Financial Officer, Jeff Trigilio, will present at the upcoming 20th Annual Needham Virtual Healthcare Conference.

Event: Needham Virtual Healthcare Conference
Date: Tuesday, April 13th
Time: 11:45am EDT
Location: Virtual

The presentation will be accessible through the Needham conference portal for registered attendees only. Investors interested in scheduling a meeting with Mr. Trigilio should contact their Needham & Company representative.

About Cullinan Oncology

Cullinan Oncology is a biopharmaceutical company that seeks to drive shareholder returns by focusing on the patient. The Company’s strategy is to build a diversified pipeline of targeted and immuno-oncology therapeutic candidates that are uncorrelated across multiple dimensions, with a focus on assets that it believes have novel technology, employ differentiated mechanisms, are in a more advanced stage of development than competing candidates, or have a combination of these attributes. Learn more about Cullinan at www.cullinanoncology.com.

Contacts:

Investor Relations
investors@cullinanoncology.com

Jeff Trigilio
+1 617.410.4650
jtrigilio@cullinanoncology.com


FAQ

When will Cullinan Oncology's CFO present at the Needham Conference?

Jeff Trigilio, CFO of Cullinan Oncology, will present at the Needham Virtual Healthcare Conference on April 13, 2021, at 11:45 am EDT.

How can investors attend Cullinan Oncology's presentation?

The presentation by Cullinan Oncology's CFO will be accessible through the Needham conference portal for registered attendees only.

What is the focus of Cullinan Oncology?

Cullinan Oncology focuses on developing a diversified pipeline of targeted and immuno-oncology therapeutic candidates, aiming to drive shareholder returns.

What is the stock symbol for Cullinan Oncology?

The stock symbol for Cullinan Oncology is CGEM.

How can investors contact Cullinan Oncology for meetings?

Investors interested in meetings with Jeff Trigilio should contact their Needham & Company representative.

Cullinan Therapeutics, Inc.

NASDAQ:CGEM

CGEM Rankings

CGEM Latest News

CGEM Stock Data

684.17M
52.75M
4.5%
118.78%
14.96%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
CAMBRIDGE